| mRNA |
BMS-536924 |
GDSC1000 |
pan-cancer |
AAC |
0.0035 |
0.9 |
| mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
| mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
| mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
| mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |